{"disease":{"id":"severe-mucocutaneous-candidiasis","name":"severe mucocutaneous candidiasis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01842386","title":"Rituximab for Anti-cytokine Autoantibody-Associated Diseases","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}